Human glucagon-like peptides 1 and 2 activate rat brain adenylate cyclase

NM Hoosein, RS Gurd - FEBS letters, 1984 - Elsevier
NM Hoosein, RS Gurd
FEBS letters, 1984Elsevier
Two human glucagon-like peptides, GLP-1 and GLP-2, which are coencoded with
pancreatic glucagon in the preproglucagon gene, do not significantly inhibit [125 I]
monoiodoglucagon binding to rat liver and brain membranes and do not activate adenylate
cyclase in liver plasma membranes. Nevertheless, GLP-1 and GLP-2 were each found to be
potent stimulators of both rat hypothalamic and pituitary adenylate cyclase. Only 30–50 pM
concentrations of each peptide elicited half-maximal adenylate cyclase stimulation. Our data …
Abstract
Two human glucagon-like peptides, GLP-1 and GLP-2, which are coencoded with pancreatic glucagon in the preproglucagon gene, do not significantly inhibit [125I]monoiodoglucagon binding to rat liver and brain membranes and do not activate adenylate cyclase in liver plasma membranes. Nevertheless, GLP-1 and GLP-2 were each found to be potent stimulators of both rat hypothalamic and pituitary adenylate cyclase. Only 30–50 pM concentrations of each peptide elicited half-maximal adenylate cyclase stimulation. Our data suggest that GLP-1 and GLP-2 may be neurotransmitters and/or neuroendocrine effectors, which would account for their high degree of sequence conservation through vertebrate evolution.
Elsevier